Former Advisory Panel Member

Steven Blum, MBA

Represented: Industry (Pharmaceutical)

Conflicts of Interest:

As of November 15, 2016:

  • Stock Owned: GlaxoSmithKline, Forest Research Institute, Inc.
  • GlaxoSmithKline, Director, Patient Reported Outcomes
  • Forest Research Institute, Director, Health Economics (prior employment in the last 12 months)

Blum served as a member of the Advisory Panel on Patient Engagement from April 2014 - April 2017.